Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]
Phase 2 trial results for ARQ-151 in children with plaque psoriasis (plaque psoriasis) evaluating maximal usage pharmacokinetics and safety;…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]
Phase 3 trial investigating ixekizumab given with tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight; …
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients [Phase 4]
Phase 4 trial evaluating topical skincare products for efficacy and tolerability in plaque psoriasis and psoriasis patients; results posted …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Daxxin Psoriasis Shampoo PMCF [NA]
The post-marketing confirmatory trial of Daxxin Psoriasis Shampoo for scalp psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
An NHLBI-sponsored clinical trial update reports the completion of the Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (P…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome [Phase 4]
Phase 4 trial comparing secukinumab 300 mg with a lifestyle intervention versus secukinumab alone in adults with moderate-to-severe psoriasi…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 trial update presents long-term safety and efficacy data for ESK-001 in adults with moderate-to-severe plaque psoriasis; the st…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis [NA]
A clinical trial investigating intermittent fasting for psoriasis and psoriatic arthritis has completed; no results are provided in the avai…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis [NA]
This clinical trial update discusses the role of Lyn tyrosine kinase and caspase-cleaved forms in psoriasis, with the study status listed as…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Guselkumab Immunogenetics [Phase 4]
Phase 4 clinical trial update for guselkumab investigating immunogenetics in psoriasis, including guttate and plaque psoriasis, currently no…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Impact of Clinical and Psychological Factors on Satisfaction With Treatment in Psoriatic Patients on Biological Therapy
A completed clinical trial evaluating how clinical and psychological factors affect patient satisfaction with biological therapy in psoriasi…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis. [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of subcutaneous tildrakizumab in adults with moderate to severe genital psoriasis;…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms [NA]
A completed trial evaluated the effectiveness of a smartphone-delivered cognitive behavioral therapy program for adults with psoriasis and c…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Improving Disease Severity [NA]
A Wake Forest University Health Sciences-sponsored clinical trial update reports a completed study aimed at improving disease severity in ps…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis [Phase 4]
A Phase 4 clinical trial evaluating dose reduction of IL-17 and IL-23 inhibitors in psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant [Phase 4]
Phase 4 trial comparing methotrexate alone versus methotrexate plus an antidepressant for patients with psoriasis and comorbid depression or…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Role of Insulin Action in Psoriasis Pathogenesis
Columbia University sponsored a clinical trial investigating the role of insulin action in psoriasis pathogenesis has been terminated. The s…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone [Phase 1]
A Phase 1 trial evaluating the combined use of cyclosporine and metformin versus cyclosporine alone for psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients [NA]
This clinical trial update notes that the study assessing fatigue in patients with psoriatic arthritis and cutaneous psoriasis has completed…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Topical SGX302 for Mild-to-Moderate Psoriasis [Phase 2]
A Phase 2 clinical trial of topical SGX302 for mild-to-moderate psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis [Phase 3]
A long-term extension study of apremilast in pediatric patients (6-17) with moderate to severe plaque psoriasis has completed in Phase 3.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis [NA]
A completed clinical trial from Hospices Civils de Lyon investigated cutaneous microcirculation and nervous sensitivity in psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis [NA]
A completed clinical trial evaluated the role of reverse transcriptase inhibitors in treating psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment [Phase 1]
A Phase 1 pharmacokinetics study evaluating Hemay005 tablets in patients with renal impairment has completed, with psoriasis listed as the c…